Sort   by:  
 Page size 
UnknownAdults with Plasmodium falciparum malaria have higher magnitude and quality of circulating T-follicular helper cells compared to children.
Not available
S-EPMC8718734 | biostudies-literature
UnknownLoss of complement regulatory proteins on red blood cells in mild malarial anaemia and in Plasmodium falciparum induced blood-stage infection.
Not available
S-EPMC6749675 | biostudies-literature
UnknownFood trade among Pacific Island countries and territories: implications for food security and nutrition.
Not available
S-EPMC9750728 | biostudies-literature
UnknownA Typology of Food Environments in the Pacific Region and Their Relationship to Diet Quality in Solomon Islands.
Not available
S-EPMC8620377 | biostudies-literature
UnknownSingle cell transcriptomics shows that malaria promotes unique regulatory responses across multiple immune cell subsets.
Not available
S-EPMC10651914 | biostudies-literature
UnknownOsteoprotegerin (OPG) and its ligands RANKL and TRAIL in falciparum, vivax and knowlesi malaria: correlations with disease severity, and B cell production of OPG.
Not available
S-EPMC11302609 | biostudies-literature
GenomicsMassive genomic rearrangement acquired in a single catastrophic event during cancer development - samples
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
EGAD00001000002 | EGA
GenomicsA Comprehensive Catalogue of Somatic Mutations from a Human Cancer Genome
We have carried out complete sequencing of the genome of the human male maligant melanoma cell line COLO-829 using the Illumina Genome Analyzer II. We generated a sequencing library with a median insert size of ~200 bp following random fragmentation and gel fractionation of the genomic DNA. We seque...
EGAS00000000052 | EGA
UnknownOsteoprotegerin and its ligands RANKL and TRAIL in falciparum, vivax, and knowlesi malaria.
Not available
S-EPMC12182329 | biostudies-literature
GenomicsMassive Genomic Rearrangment Acquired in a Single Catastrophic Event During Cancer Development
Cancer is driven by mutation. Using Agilent exome hybridisation capture and Illumina GA massively parallel sequencing technology, we aim to sequence ~1600 microRNAs plus the protein coding genome of 25 matched human renal cancer samples. Bespoke algorithms are being developed to identify the somatic...
EGAS00000000029 | EGA
Sort   by:  
 Page size